Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heron Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Heron Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Equity Offering 12
Heron Therapeutics Raises USD200 Million in Public Offering of Shares 12
Heron Therapeutics Prices Public Offering of Shares for USD156 Million 14
Heron Therapeutics Prices Public Offering of Shares for USD150 Million 16
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 17
Heron Therapeutics Raises USD137 Million in Public Offering of Shares 19
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 21
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 23
A.P. Pharma Completes Public Offering Of Shares For US$60 Million 24
A.P. Pharma Completes Private Placement Of Common Stock For US$54 Million 26
Heron Therapeutics Inc – Key Competitors 27
Heron Therapeutics Inc – Key Employees 28
Heron Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Sep 30, 2018: Heron Therapeutics announces financial results for the three and nine months ended September 30, 2018 and recent corporate progress 30
Aug 08, 2018: Heron Therapeutics announces financial results for the three and six months ended june 30, 2018 and recent corporate progress 31
May 10, 2018: Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress 32
Feb 27, 2018: Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress 34
Nov 06, 2017: Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress 36
Aug 09, 2017: Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 37
May 10, 2017: Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 38
Feb 23, 2017: Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress 39
Corporate Communications 40
Apr 24, 2017: Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, Finance 40
Clinical Trials 41
Mar 19, 2018: Heron Announces Positive Topline Results From Pivotal Phase 3 Clinical Trials of HTX-011 in Bunionectomy and Hernia Repair 41
Oct 26, 2017: Heron Therapeutics Granted FDA Fast Track Designation for HTX-011 to Reduce Postoperative Pain and the Need for Opioid Analgesics for 72 Hours 43
Aug 09, 2017: Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA 44
Jan 04, 2017: Heron Therapeutics Announces Positive Topline Results From Phase 2 Clinical Trial of HTX-011 in Abdominoplasty 46
Jan 04, 2017: Heron Therapeutics Establishes Synergy of Bupivacaine and Meloxicam with HTX-011 for Prevention of Post-Operative Pain in Phase 2 Clinical Studies 47
Other Significant Developments 48
Jan 08, 2018: Heron Therapeutics Highlights Progress in CINV and Pain Management Franchises 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heron Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heron Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Heron Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Heron Therapeutics Raises USD200 Million in Public Offering of Shares 12
Heron Therapeutics Prices Public Offering of Shares for USD156 Million 14
Heron Therapeutics Prices Public Offering of Shares for USD150 Million 16
Heron Therapeutics Raises USD172.6 Million in Public Offering of Shares 17
Heron Therapeutics Raises USD137 Million in Public Offering of Shares 19
Heron Therapeutics Raises USD55.8 Million in Public Offering of Shares 21
Heron Therapeutics Raises USD7 Million in Private Placement of Warrants 23
A.P. Pharma Completes Public Offering Of Shares For US$60 Million 24
A.P. Pharma Completes Private Placement Of Common Stock For US$54 Million 26
Heron Therapeutics Inc, Key Competitors 27
Heron Therapeutics Inc, Key Employees 28
Heron Therapeutics Inc, Other Locations 29
List of Figures
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Heron Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10